Home Daily Stock Opinions and Ratings Envista Holdings (NVST-N)

Trending stocks today

ENI SPA Clairvest Group Inc Melcor Developments Ltd Suncor Energy Inc Toronto Dominion (TD) Kakaku.com, Inc. Credit Acceptance Corp Brookfield Infrastructure Partners Sun Life Financial Inc Amazon.com, Inc. Crescent Point Energy Corp Rogers Communications (B) Pfizer Inc Minto Apartment REIT Winpak Ltd. Arc Resources Ltd Cenovus Energy Headwater Exploration Inc. Whitecap Resources

Envista Holdings (NVST-N)

22 watching

NYSE:NVST

32.98
0.29 (0.87%) 1d
May 30, 2023, 8:00 pm
0
PAST TOP PICK

Envista Holdings(NVST-N)

18/10/2022
Envista Holdings
(A Top Pick Oct 13/21, Down 11%) Likes it because the dental penetration rate in emerging markets remains low, though it's a mature market in North America. Only a third of the population in the latter holds no dental coverage, so fears of a recession have pressured shares. Also, their exposure to Russia and China haven't hurt, though it has been recovering in China. Aging demographics is seeing maintaining teeth rather than dentures.
Healthcare
Christine Poole
$33.710
Owned
UnlockRating
PAST TOP PICK

Envista Holdings(NVST-N)

20/09/2022
Envista Holdings

(A Top Pick Sep 14/21, Down 23%) A leading provider of dental products and services. A spin-off from Danaher. A reason NVST is down is that dental expenses are only partially (50%) covered by plans, so people may defer going to the dentist. Also, 15% of their revenues are from Russia and China (impacted by lockdowns). That's a hiccup. Is trading cheaply now, and she likes the long-term prospects. NVST is introducing new popular products like new implants.

Healthcare
Christine Poole
$33.290
Owned
UnlockRating
BUY

Envista Holdings(NVST-N)

15/03/2022
Envista Holdings

She started buying this last year. They revamped their dental product lines, which are doing well. Dental care has room to grown in emerging, markets, though mature in North America. She sees 10% upside one year out. Likes it.

Healthcare
Christine Poole
$45.010
Owned
UnlockRating
BUY

Envista Holdings(NVST-N)

18/01/2022
Envista Holdings
A past top pick. She likes their long-term growth outlook because of demographics and penetrating emerging markets where dentistry penetration remains low. Danaher spun out Envista to focus more on healthcare R&D, which has worked out. She sees mid-single-digit top-line growth and margin improvement in NVST.
Healthcare
Christine Poole
$45.695
Owned
UnlockRating
BUY

Envista Holdings(NVST-N)

14/12/2021
Envista Holdings
It got spun out in late 2019. The dental sector has a lot of room to grow as the population ages and needs more dental care in North America. In developing markets there's a lot of room to grow; they need more dental hygiene. ENST has been investing in R&D, previously lagging, and are now leaders in implants. Lots going on. They sell products directly and indirectly, so they have channels to sell new innovative products. Trades at a reasonable PE.
Healthcare
Christine Poole
$39.600
Unknown
UnlockRating
BUY ON WEAKNESS

Envista Holdings(NVST-N)

16/11/2021
Envista Holdings
Reported a good quarter. Her target price is closer to $50, so she's not buying it right now. On a weak day, you could start or add to your position.
Healthcare
Christine Poole
$43.355
Owned
UnlockRating
TOP PICK

Envista Holdings(NVST-N)

13/10/2021
Envista Holdings
Dental products, with a broad range. Spun off from Danaher, allowing them to focus on improvements. Quite global, with only 48% of revenues coming from North America. Leading player in implants, a growing segment. Good growth in both developed and developing markets. Likes the valuation and its industry position. No dividend. (Analysts’ price target is $50.57)
Healthcare
Christine Poole
N/A
Owned
UnlockRating
BUY

Envista Holdings(NVST-N)

14/09/2021
Envista Holdings
They make dental products. She likes the dental industry for its secular growth, specifically from aging demographics (a desire to keep your teeth longer which feeds the implant business), and a low penetration rate in developing markets. 22% of their revenues come from emerging markets, plus 50% from North America. There's a lot of room for NVST to grow and they have a broad product offering, supplying 90% of the equipment of what a dentist needs. They lead in many product categories. They just launched the Sparks clear dental liner which is enjoying strong growth int he U.S., the first innovation in years. They're #1 in the implant business. (Analysts’ price target is $51.75)
Healthcare
Christine Poole
$43.520
Owned
UnlockRating
Showing 1 to 8 of 8 entries
  • «
  • ‹
  • 1
  • ›
  • »

Envista Holdings(NVST-N) Rating

Ranking : 4 out of 5

Bullish - Buy Signals / Votes : 2

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 2

Stockchase rating for Envista Holdings is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Envista Holdings(NVST-N) Frequently Asked Questions

What is Envista Holdings stock symbol?

Envista Holdings is a American stock, trading under the symbol NVST-N on the New York Stock Exchange (NVST). It is usually referred to as NYSE:NVST or NVST-N

Is Envista Holdings a buy or a sell?

In the last year, 2 stock analysts published opinions about NVST-N. 2 analysts recommended to BUY the stock. 0 analysts recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for Envista Holdings.

Is Envista Holdings a good investment or a top pick?

Envista Holdings was recommended as a Top Pick by on . Read the latest stock experts ratings for Envista Holdings.

Why is Envista Holdings stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Envista Holdings worth watching?

2 stock analysts on Stockchase covered Envista Holdings In the last year. It is a trending stock that is worth watching.

What is Envista Holdings stock price?

On 2023-05-30, Envista Holdings (NVST-N) stock closed at a price of $32.98.

Your Watchlist

Add stocks to watchlist to monitor them daily and get important alerts.

Get Access To Watchlist

Latest Buy Signals

JAZZ-QJazz Pharmaceuticals
Jazz Pharmaceuticals
$128.16
1.32 (1.02%)
CRM-NSalesForce.com Inc.
SalesForce.com Inc.
$223.38
4.51 (1.98%)
AMAT-QApplied Materials
Applied Materials
$133.46
-3.11 (-2.39%)
NFE-QNew Fortress Energy
New Fortress Energy
$26.27
-0.18 (-0.69%)
ENPH-QEnphase Energy
Enphase Energy
$173.88
-0.24 (-0.14%)
Advertising

Today's Top Picks

WCP-TWhitecap Resources
Whitecap Resources
$9.29
-0.26 (-2.88%)
HWX-THeadwater Exploration Inc.
Headwater Exploration Inc.
$6.29
-0.16 (-2.53%)
CVE-TCenovus Energy
Cenovus Energy
$21.69
-0.51 (-2.41%)
ARX-TArc Resources Ltd
Arc Resources Ltd
$16.36
-0.34 (-2.12%)
WPK-TWinpak Ltd.
Winpak Ltd.
$42.69
-0.13 (-0.31%)

Popular Articles

Questrade Review: Pros & Cons of Trading with Questrade Canada (2021) Steady Eddys: 3 Stable Stocks Between Safety and Risk: 3 Safe and Gambling Stocks 3 Oversold Stocks to Take Advantage of 5 ETFs for Index Investing

Latest Sell Signals

M-NMacys Inc. (formerly Federated Department Stores)
Macys Inc. (formerly Federated Department Stores)
$13.59
-0.52 (-3.98%)
DVN-NDevon Energy Corp
Devon Energy Corp
$46.10
-0.86 (-1.90%)
PIPE-TPipestone Energy Corp.
Pipestone Energy Corp.
$2.29
-0.10 (-4.57%)
VRML-QVermillion Inc
Vermillion Inc
$4.00
0.00 (0.00%)
FRU-TFreehold Royalties Ltd
Freehold Royalties Ltd
$14.00
-0.35 (-2.56%)

Most Recent Experts

Nuttall

Eric Nuttall

Ninepoint Partners

Stockchase

Stockchase Insights

5i Research

Cramer

Jim Cramer - Mad Money

CNBC

Zechner

John Zechner

J. Zechner & Assoc

Stockchase

Stockchase Discover

Stockchase

Advertising
Advertising
logoTop pickslogoStockslogoRecentlogoWatchlist
© Stockchase Inc.